氧化剂-抗氧化剂状态的调查在患者治疗 hirudotherapy:一个实验性研究研究
Ismail Sarikan1, Hasan Basri Savas1
1Alaaddin keykubat University, Antalya, Turkey.
概括
希鲁多疗法可能有助于减少氧化应激. 这项研究发现,虽然一些氧化应激标志物在水疗法后下降,但只有二硫化物水平显示出显著的减少.
科学领域:
- 生物医学科学 生物医学科学
- 补充医学是一种补充医学.
背景情况:
- 氧化应激与各种疾病有关.
- 希鲁多疗法是一种具有潜在治疗效果的传统治疗方法.
研究的目的:
- 研究希鲁多疗法对成年志愿者氧化应激关键标志物的影响.
主要方法:
- 一项涉及50名成年志愿者进行两次hirudotherapy会话的横截面研究.
- 在治疗前和治疗后评估总抗氧化剂状况,总氧化剂状况,氧化应激指数,缺血病修饰性白蛋白,氧化酶1,二硫化物,原生硫醇,总硫醇和烯酶水平.
主要成果:
- 在hirudotherapy后观察到氧化压力,缺血症修饰的白蛋白和二硫化物水平的下降.
- 脱硫化物水平的降低是统计学上显著的 (p=0.021).
- 在其他测量氧化应激参数 (p>0.05) 中没有发现显著变化.
结论:
- 希鲁多疗法显示出降低氧化应激,特别是二硫化物水平的潜力.
- 需要进一步的研究来证实这些发现,并探索涉及的机制.
相关概念视频
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686


